Europe’s cost of living crisis jeopardises medication adherence
BMJ · 2023
DOI: 10.1136/bmj.p747 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ, 2023. Verfasst von Tamas Agh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pecs, Hungary. Hauptthemen laut MEDLINE: Public Policy, Medication Adherence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Care must be taken to ensure that economic hardship doesn’t lead to medication non-adherence and entrench social inequalities, write Tamas Agh and colleagues
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pecs, Hungary.
- Syreon Research Institute, Hungary.
- Department of Clinical Pharmacy & Pharmacology, Medication Adherence Expertise Center of the northern Netherlands (MAECON), University Medical Center Groningen, University of Groningen, the Netherlands.
- Medication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Poland.
Zitieren
APA
Agh, T., van Boven, J. F., & Kardas, P. (2023). Europe’s cost of living crisis jeopardises medication adherence. BMJ. https://doi.org/10.1136/bmj.p747
Vancouver
Agh T, van Boven JF, Kardas P. Europe’s cost of living crisis jeopardises medication adherence. BMJ. 2023. doi:10.1136/bmj.p747
BibTeX
@article{Agh2023,
author = {Agh, Tamas and van Boven, Job Fm and Kardas, Przemyslaw},
title = {Europe’s cost of living crisis jeopardises medication adherence},
journal = {BMJ},
year = {2023},
doi = {10.1136/bmj.p747}
}
EUVIMED